CytoReason is developing the first cell-centered computational model of human disease. With the company’s proprietary database and AI-led platform, pharma and biotech companies minimize the need for animal trials and make human trials more focused and accurate. To date, five of the world’s top ten pharma companies, including Pfizer, Janssen and Roche, use CytoReason’s technology to reach data-driven decisions and develop new drugs in a fraction of the time and cost.

Over the last decade, biology has been transformed. Less mice and microscopes, more technology and human data. To feel comfortable and excel in this new space, biologists and bioinformaticians, data engineers and software developers, need to sit together in the same room, speak the same language and work together towards the same goals.

At CytoReason, you’ll work with a multidisciplinary team and tackle the industry’s most burning questions. Along the way, you’ll help the world’s top pharma companies enter the era of precision medicine, make groundbreaking discoveries, and bring novel therapies to the patients who most need them.